Compare C3.ai Inc (AI) vs Alcon AG (ALC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
C3.ai Inc vs Alcon AG — how do they compare? C3.ai Inc trades at $10.54 (market cap $1.65B), while Alcon AG trades at $72.61 (market cap $36.44B). The key difference: Alcon AG is far larger — about 22.1× C3.ai Inc's market cap, and Alcon AG pays a 0.48% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | ALC | |
|---|---|---|
Market Cap | $1.65B | $36.44B |
Sector | Technology | Health |
52-Week High | $19.66 | $90.12 |
52-Week Low | $7.76 | $62.02 |
Enterprise Value | $1.08B | $40.28B |
Dividend Yield | — | 0.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →
